These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6385952)

  • 1. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction.
    Bedossa P; Bendelac A; Bach JF; Carnaud C
    Eur J Immunol; 1989 Oct; 19(10):1947-51. PubMed ID: 2684673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
    Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
    J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
    Scherbaum WA; Seissler J
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting of islet autoantigens.
    Stadinski B; Kappler J; Eisenbarth GS
    Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of type 1 diabetes.
    Campbell IL; Harrison LC
    Mol Biol Med; 1990 Aug; 7(4):299-309. PubMed ID: 2233244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H
    Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
    Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications].
    Timsit J; Boitard C; Bach JF
    Ann Biol Clin (Paris); 1991; 49(3):149-53. PubMed ID: 2064084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.